234 related articles for article (PubMed ID: 26383967)
1. XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma.
Cheng J; Liu W; Zeng X; Zhang B; Guo Y; Qiu M; Jiang C; Wang H; Wu Z; Meng M; Zhuang H; Zhao L; Hao J; Cai Q; Xie D; Pang Q; Wang P; Yuan Z; Qian D
Cancer Sci; 2015 Dec; 106(12):1678-86. PubMed ID: 26383967
[TBL] [Abstract][Full Text] [Related]
2. The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.
Qian D; Zhang B; He LR; Cai MY; Mai SJ; Liao YJ; Liu YH; Lin MC; Bian XW; Zeng YX; Huang JJ; Kung HF; Xie D
J Pathol; 2013 Apr; 229(5):765-74. PubMed ID: 23341363
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human positive cofactor 4 radiosensitizes human esophageal squmaous cell carcinoma cells by suppressing XLF-mediated nonhomologous end joining.
Qian D; Zhang B; Zeng XL; Le Blanc JM; Guo YH; Xue C; Jiang C; Wang HH; Zhao TS; Meng MB; Zhao LJ; Hao JH; Wang P; Xie D; Lu B; Yuan ZY
Cell Death Dis; 2014 Oct; 5(10):e1461. PubMed ID: 25321468
[TBL] [Abstract][Full Text] [Related]
4. The AEG-1-USP10-PARP1 axis confers radioresistance in esophageal squamous cell carcinoma via facilitating homologous recombination-dependent DNA damage repair.
Zhao X; Ma Y; Li J; Sun X; Sun Y; Qu F; Shi X; Xie Y; Liu S; Ma Y; Ji C; Hu W; Che S; Zhang X
Cancer Lett; 2023 Nov; 577():216440. PubMed ID: 37838281
[TBL] [Abstract][Full Text] [Related]
5. Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells.
Zhan L; Qin Q; Lu J; Liu J; Zhu H; Yang X; Zhang C; Xu L; Liu Z; Cai J; Ma J; Dai S; Tao G; Cheng H; Sun X
Dis Esophagus; 2016 Apr; 29(3):215-23. PubMed ID: 25604309
[TBL] [Abstract][Full Text] [Related]
6. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
[TBL] [Abstract][Full Text] [Related]
7. Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51.
Liu Q; Jiang H; Liu Z; Wang Y; Zhao M; Hao C; Feng S; Guo H; Xu B; Yang Q; Gong Y; Shao C
PLoS One; 2011; 6(8):e23427. PubMed ID: 21858113
[TBL] [Abstract][Full Text] [Related]
8. The ATPase subunit of ATP6V1C1 inhibits autophagy and enhances radiotherapy resistance in esophageal squamous cell carcinoma.
Yao X; Chen H; Xu B; Lu J; Gu J; Chen F; Ju M; Sun X
Gene; 2021 Feb; 768():145261. PubMed ID: 33183740
[TBL] [Abstract][Full Text] [Related]
9. High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma.
Di X; He G; Chen H; Zhu C; Qin Q; Yan J; Zhang X; Sun X
J Gastroenterol Hepatol; 2019 Apr; 34(4):728-735. PubMed ID: 29968320
[TBL] [Abstract][Full Text] [Related]
10. REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2.
Gu C; Luo J; Lu X; Tang Y; Ma Y; Yun Y; Cao J; Cao J; Huang Z; Zhou X; Zhang S
Cancer Sci; 2019 Mar; 110(3):962-972. PubMed ID: 30657231
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of microRNA-136 induces apoptosis and radiosensitivity of esophageal squamous cell carcinoma cells by inhibiting the expression of MUC1.
Huang HZ; Yin YF; Wan WJ; Xia D; Wang R; Shen XM
Exp Mol Pathol; 2019 Oct; 110():104278. PubMed ID: 31247211
[TBL] [Abstract][Full Text] [Related]
12. NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.
Wang Y; Cheng J; Xie D; Ding X; Hou H; Chen X; Er P; Zhang F; Zhao L; Yuan Z; Pang Q; Wang P; Qian D
Cancer Commun (Lond); 2018 Jun; 38(1):33. PubMed ID: 29871674
[TBL] [Abstract][Full Text] [Related]
13. RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p-DNA-PKcs.
Li X; Zou S; Zhou L; Gao A; Xu J; He C; Zhou J; Wu S; Chen Y
Cancer Med; 2022 Oct; 11(20):3809-3819. PubMed ID: 35426246
[TBL] [Abstract][Full Text] [Related]
14. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
[TBL] [Abstract][Full Text] [Related]
15. [High throughput-targeted sequencing panel for exploring radiosensitivity associated genes in esophageal squamous cell carcinoma].
Qiao Y; Hu CX; Song DA; Li SQ; Zhou LH; Jiang XD
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):584-588. PubMed ID: 28835080
[No Abstract] [Full Text] [Related]
16. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p-EGFR and p-ERK.
Zhao G; Feng L; Ye T; Liu Y; Fan L; Ye C; Chen J
Thorac Cancer; 2023 Aug; 14(22):2127-2138. PubMed ID: 37337933
[TBL] [Abstract][Full Text] [Related]
17. SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.
Sugase T; Takahashi T; Serada S; Fujimoto M; Hiramatsu K; Ohkawara T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Kishimoto T; Mori M; Doki Y; Naka T
Cancer Res; 2017 Dec; 77(24):6975-6986. PubMed ID: 29042418
[TBL] [Abstract][Full Text] [Related]
18. PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.
Park M; Yoon HJ; Kang MC; Kwon J; Lee HW
Tumour Biol; 2016 Oct; 37(10):14217-14224. PubMed ID: 27557627
[TBL] [Abstract][Full Text] [Related]
19. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
20. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
